Latest filing published 05 Jan 2021 for ImmunoGen, Inc., €1,189.
Filing timeline
BuySaleInsider track record
David G. Foster: trading record in brief
David G. Foster appears in our data through filings on ImmunoGen, Inc. shares, published by SEC (Form 4). In total, 9 filings cover trades dated from 3 January 2019 to 31 December 2020.
Every open-market trade on record is a sale: 2 sales worth €75k. Outside the open market, there are 5 share grants and 2 option exercises. Since January 2021: no purchases and 1 sale on the market.
Most recently, on 5 January 2021, the filings show a share grant worth €1,189 in ImmunoGen, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to David G. Foster
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 362 shares@ US$4.041.3% of flowCommon StockSEC:0001179110-21-000082:0
- 27,240 sharesCommon StockSEC:0001179110-21-000066:0
- 11,052 shares@ US$6.3864.3% of flowCommon StockSEC:0001179110-21-000066:1
- 342 shares@ US$3.916.1% of flowCommon StockSEC:0001179110-20-007820:0
- 5,448 shares@ US$3.4367.9% of flowCommon StockSEC:0001179110-20-004487:1
- 18,160 sharesCommon StockSEC:0001179110-20-004487:0
- 662 shares@ US$1.993.8% of flowCommon StockSEC:0001179110-20-000181:0
- 3,536 shares@ US$1.8418.8% of flowCommon StockSEC:0001179110-19-008314:0
- 1,472 shares@ US$4.0817.3% of flowCommon StockSEC:0001179110-19-000359:0
9 of 9 declarations
